Vista Pharmaceuticals share news and announcements

BSE: 524711Pharmaceuticals & BiotechnologySmall Cap

₹5.84₹0.36 (6.57%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹5.48.

52-week range of traded prices to 23 Oct 2026

₹5.32Low, 16 Sep 2026₹10.50High, 23 Oct 2025

Market cap: ₹36 Cr3,508th largest listed
P/E: Lossover the last 12 months
P/B: 1.0
Dividend yield: Nonein the last 12 months
ROE: −28.7%
ROCE: −32.5%
Debt to equity: 0.27
Volume, BSE: 6,933

Vista Pharmaceuticals share news and announcements

532 announcements, routine notices left out, newest first. Page 5 of 11.

Mar 2021
- 22 Mar · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bojja Sreenivasulu (opens in a new tab)
Feb 2021
- 12 Feb · Results
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Friday, 12th February,2021 at 4.30 P.M. at the Corporate office .... (opens in a new tab)
- 12 Feb · Board meeting
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Friday, 12th February, 2021 at 4:30 PM, at the corporate office .... (opens in a new tab)
- 2 Feb · Board meeting
  Meeting on 12 Feb 2021: quarterly results
- 2 Feb · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve With reference to the .... (opens in a new tab)
Jan 2021
- 13 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 11 Jan · Shareholding for the Period Ended December 31, 2020
  Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....
Dec 2020
- 30 Dec · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 30 Dec · Meeting
  We write to inform you that the members of the Company have approved all the resolutions .... (opens in a new tab)
- 29 Dec · Meeting
  Outcome/Proceedings - 29th Annual General Meeting of the Company held on Tuesday, 29th September, 2020 at 04.30 P.M. and concluded at 4.50 PM through Video Conferencing (VC) / Other Audio .... (opens in a new tab)
- 22 Dec · Legal
  We would like to submit that the company had not provided or released any price sensitive information to the investor other than the intimation of post Annual General Meeting compliance's .... (opens in a new tab)
- 10 Dec · Legal
  Exchange has sought clarification from Vista Pharmaceuticals Ltd on December 10, 2020, with reference to Movement in Price. The reply is awaited.
- 7 Dec · Meeting
  With reference to the above captioned subject, It is hereby informed to the members of the company that 29th Annual general Meeting for the Financial Year 2019-2020 to be held on Tuesday, .... (opens in a new tab)
- 7 Dec · Reg. 34 (1) Annual Report
  In Compliance with Regulation 34 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015, we herewith submit the 29th Annual Report for the Financial Year 2019-2020 .... (opens in a new tab)
- 7 Dec · Reg. 34 (1) Annual Report
  In Compliance with Regulation 34 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015, we herewith submit the 29th Annual Report for the Financial Year 2019-2020 .... (opens in a new tab)
- 1 Dec · Meeting
  With reference to the subject cited, it is hereby brought to the notice that management of M/s. Vista Pharmaceuticals Limited is proposing to call the Annual General Meeting for the financial .... (opens in a new tab)
Nov 2020
- 12 Nov · Management
  In pursuance of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD1/114/2019 dated October 18, 2019, this .... (opens in a new tab)
- 12 Nov · Results
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Thursday, 12th November, 2020 at 4.30 P.M. at the corporate .... (opens in a new tab)
- 12 Nov · Board meeting
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Thursday, 12th September, 2020 at 4:30 PM, at the corporate .... (opens in a new tab)
- 5 Nov · Board meeting
  Meeting on 12 Nov 2020: quarterly results
- 5 Nov · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve With reference to the .... (opens in a new tab)
Oct 2020
- 23 Oct · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-For The Half Year Ended 30.09.2020.
  We here submit the Compliance Certificate certifying that we are maintaining all .... (opens in a new tab)
- 23 Oct · Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
  With reference to the subject matter cited and pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith certificate .... (opens in a new tab)
- 16 Oct · Shareholding for the Period Ended September 30, 2020
  Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....
- 14 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2020
- 14 Sep · Results
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Monday, 14th September, 2020 at 4.00 P.M. at the Corporate office .... (opens in a new tab)
- 14 Sep · Results
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Monday, 14th September, 2020 at 4:00 PM, at the corporate office .... (opens in a new tab)
- 7 Sep · Board meeting
  Meeting on 14 Sep 2020: quarterly results
- 7 Sep · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/09/2020 ,inter alia, to consider and approve With reference to the .... (opens in a new tab)
Aug 2020
- 18 Aug · Management
  With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited held today, i.e., 18th August, 2020 .... (opens in a new tab)
- 18 Aug · Management
  Dear Sir/Ma'am, With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited held today, .... (opens in a new tab)
- 13 Aug · Shareholding for the Period Ended August 03, 2020
  Shareholding Pattern for the Period Ended August 03, 2020. For more details, kindly Click ....
- 7 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anand Chittajallu (opens in a new tab)
- 6 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Umakanth Katta (opens in a new tab)
- 3 Aug · Announcement under Regulation 30 (LODR)-Allotment
  With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited held today, i.e., 03rd August, 2020 .... (opens in a new tab)
Jul 2020
- 29 Jul · Results
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Wednesday, 29th July, 2020 at 04.30 P.M. at the Corporate office .... (opens in a new tab)
- 29 Jul · Board meeting
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Wednesday, 29th July, 2020 at 04:30 PM, at the corporate office .... (opens in a new tab)
- 21 Jul · Shareholding for the Period Ended July 13, 2020
  Shareholding Pattern for the Period Ended July 13, 2020. For more details, kindly Click ....
- 21 Jul · Shareholding for the Period Ended July 07, 2020
  Shareholding Pattern for the Period Ended July 07, 2020. For more details, kindly Click ....
- 20 Jul · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2020 ,inter alia, to consider and approve With reference to the .... (opens in a new tab)
- 15 Jul · Disclosure
  Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Umakanth Katta (opens in a new tab)
- 14 Jul · Shareholding for the Period Ended June 30, 2020
  Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....
- 14 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 13 Jul · Announcement under Regulation 30 (LODR)-Allotment
  With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited held today, i.e., 13th July, 2020 .... (opens in a new tab)
- 13 Jul · Board meeting
  Meeting on 20 Jul 2020: audited results and quarterly results
- 12 Jul · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2020 ,inter alia, to consider and approve With reference to the .... (opens in a new tab)
- 9 Jul · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UmakanthKatta (opens in a new tab)
- 7 Jul · Announcement under Regulation 30 (LODR)-Allotment
  Dear Sir/Ma'am, With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited held today, .... (opens in a new tab)
Jun 2020
- 29 Jun · Results
  Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 28 Jun · Results
  Pursuant to the provision of Sections 108 and 110 of the Companies Act, 2013, read with the Companies (Management and Administration) Rules, 2014, as amended from time to time, the Company .... (opens in a new tab)

Vista Pharmaceuticals share news and announcements

Mar 2021

Feb 2021

Jan 2021

Dec 2020

Nov 2020

Oct 2020

Sep 2020

Aug 2020

Jul 2020

Jun 2020